Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. PINK /
  3. AAVXF.PINK

ABIVAX Société Anonyme (AAVXF PINK) stock market data APIs

$15.15 0(0%) as of July 25, 2024
Price chart is built with Anychart

ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to stablize the immune response in patients with chronic inflammatory diseases. The company is evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis in adults. ABIVAX Société Anonyme was incorporated in 2013 and is headquartered in Paris, France.

ABIVAX Société Anonyme Financial Data Overview

15.15
15.15
-
15.15
15.15
10.19-20
1 258 M
62 918 K
4 493 K
-0.9447
1.479
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'AAVXF',
Type: 'Common Stock',
Name: 'ABIVAX Société Anonyme',
Exchange: 'PINK',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00DX9WMJ1',
ISIN: NULL,
CUSIP: NULL,
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

ABIVAX Société Anonyme Fundamental Data is available in our Financial Data APIs

  • Net Revenue 4 493 K
  • EBITDA -127 251 000
  • Earnings Per Share -3.75
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get ABIVAX Société Anonyme Earnings via APIs

  • Latest Release 2020-12-31
  • EPS/Forecast 0

Get ABIVAX Société Anonyme End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get ABIVAX Société Anonyme latest news via APIs

Abivax Announces the Appointment of June Lee, M.D. and Troy Ignelzi as Members of the Board of Directors

PARIS, FRANCE / ACCESSWIRE / July 11, 2023 / Abivax SA (Euronext Paris: FR0012333284 - ABVX), a Phase 3 clinical-stage biotechnology company focused on developing therapeutics that modulate the immune...

Abivax receives "Capital Market Transaction of the Year Award" at the European Mediscience Awards 2023

The award recognizes a significant capital market transaction in the biotech sector Abivax received the award for its oversubscribed EUR 130M cross-over financing at market price with top-tier US and ...
Do you have any questions?
support@eodhistoricaldata.com